Abpro Holdings, Inc. (ABPO)
0.2293
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Abpro Holdings Shareholders Equity (Quarterly) : -3.533M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.533M |
| March 31, 2026 | -2.801M |
| December 31, 2025 | -8.831M |
| September 30, 2025 | -16.14M |
| June 30, 2025 | -17.50M |
| March 31, 2025 | -18.36M |
| December 31, 2024 | -15.50M |
| September 30, 2024 | -11.68M |
| June 30, 2024 | -9.910M |
| March 31, 2024 | -9.571M |
| Date | Value |
|---|---|
| December 31, 2023 | -13.38M |
| September 30, 2023 | 21.51M |
| June 30, 2023 | 21.56M |
| March 31, 2023 | 299.99M |
| December 31, 2022 | 297.92M |
| September 30, 2022 | 296.46M |
| June 30, 2022 | 295.81M |
| March 31, 2022 | 296.01M |
| December 31, 2021 | 0.0232M |
| October 31, 2021 | 0.024M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.241M |
| Total Liabilities (Quarterly) | 8.225M |
| Debt to Equity Ratio | -0.0484 |
| Current Ratio | 0.6175 |
| Net Debt Paydown Yield | 52.38% |